Invention Grant
- Patent Title: Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma
-
Application No.: US16343323Application Date: 2017-11-07
-
Publication No.: US11058691B2Publication Date: 2021-07-13
- Inventor: Jason Lamar Vittitow , Megan Elizabeth Cavet
- Applicant: BAUSCH & LOMB INCORPORATED , NICOX S.A.
- Applicant Address: US NY Rochester; FR Valbonne
- Assignee: BAUSCH & LOMB INCORPORATED,NICOX S.A.
- Current Assignee: BAUSCH & LOMB INCORPORATED,NICOX S.A.
- Current Assignee Address: US NY Rochester; FR Valbonne
- Agency: Arent Fox LLP
- International Application: PCT/EP2017/078486 WO 20171107
- International Announcement: WO2018/087092 WO 20180517
- Main IPC: A61K31/5575
- IPC: A61K31/5575 ; A61P27/06 ; A61K45/06
Abstract:
This invention provides a method of lowering intraocular pressure in a patient having normal tension glaucoma, comprising contacting an eye of a subject having normal tension glaucoma with a pharmaceutical composition comprising an effective amount of Nitric Oxide releasing prostaglandin derivatives of formula (I).
Public/Granted literature
- US20200179401A1 NITRIC OXIDE RELEASING PROSTAGLANDIN DERIVATIVES FOR TREATING NORMAL TENSION GLAUCOMA Public/Granted day:2020-06-11
Information query
